Novuson Surgical, Inc. Email Format
Medical Equipment ManufacturingWashington, United States11-50 Employees
Novuson Surgical, Inc. is a medical equipment manufacturer focused on developing Direct Therapeutic Ultrasound (DTU) technology for coagulation and hemostatic control in surgical and trauma settings. The company aims to enable faster procedures and more rapid bleeding control, addressing limitations of existing methods that rely on electrical currents or friction heat. Headquartered in Bothell, Washington, the organization emerged as a spinout from the University of Washington’s Applied Physics Laboratory, Center for Industrial and Medical Ultrasound, and is led by founders Stuart B. Mitchell, PhD, and Francesco P. Curra, PhD. Novuson operates within the medical device industry, positioning itself as an innovator in vessel sealing, division, and hemostasis for surgical and trauma applications. Its current status indicates the technology is not yet commercially available for sale, with recent organizational developments including the appointment of a senior executive to drive market expansion. The company has pursued capital-raising activity through a Regulation Crowdfunding initiative and maintains a focus on advancing its DTU platform for clinical use.